Prostate MRI Detects More Cancers Than Standard US-Guided Biopsy
Apr 19, 2018
MR imaging of the prostate detects more treatable cancers and reduces overdiagnosis than standard ultrasound-guided biopsies.
Recent Content
|
|
Supplemental MRI Screening for Breast Cancer Greatly UnderutilizedApr 19, 2018 Supplemental MR imaging for women at higher risk for breast cancer is not done frequently enough. |
 Meet the Challenge of Image Storage DemandsApr 19, 2018 Storage capabilities are being overwhelmed by ballooning image sizes. Do you have the required bandwidth? |
Thyroid Imaging Reporting and Data System Reduces BiopsiesApr 18, 2018 Using the American College of Radiology Thyroid Imaging Reporting and Data System criteria results in fewer biopsies and more accurate recommendations. |
Delay Phase in Enhanced MRI Increases Diagnosis of Hepatocellular CarcinomaApr 18, 2018 A 15-minute delayed phase when performing extra-cellular contrast agent enhanced MR imaging may improve diagnosis of hepatocarcinoma. |
 That Doesn’t HelpApr 18, 2018 Reasonable expectations are far from universally gratified in radiology. |
 Radiology Comic: What to Do With Outdated EquipmentApr 12, 2018 A creative solution for dealing with outdated radiology equipment. |
Fewer Screening Mammography Recalls Associated with More Interval Breast CancersApr 12, 2018 More interval breast cancers detected when screening mammography recall rates are low. |
3D T2-Weighted Imaging Could Shorten Prostate MRI ProtocolsApr 11, 2018 Three-dimensional imaging could provide equivalent image quality to 2D acquisitions in T2-weighted imaging of the prostate at 3T. |
Not Quite Striving for PerfectionApr 11, 2018 Spelling—and anatomy—count when it comes to quality medicine. |